Treating Parkinson's disease in the 21st century: can stem cell transplantation compete?
Treating Parkinson's disease in the 21st century: can stem cell transplantation compete?
复制标题
DOI：
10.1002/cne.23577
复制
发表时间：
2014-08-15
影响因子：
2.5
通讯作者：
Barker, Roger A.
中科院分区：
文献类型：
--
作者：
Buttery, Philip C.;Barker, Roger A.
The characteristic and selective degeneration of a unique population of cells—the nigrostriatal dopamine (DA) neurons—that occurs in Parkinson’s disease (PD) has made the condition an iconic target for cell replacement therapies. Indeed, transplantation of fetal ventral mesencephalic cells into the DA-deficient striatum was first trialled nearly 30 years ago, at a time when other treatments for the disease were less well developed. Over recent decades standard treatments for PD have advanced, and newer biological therapies are now emerging. In the 21st century, stem cell technology will have to compete alongside other sophisticated treatments, including deep brain stimulation and gene therapies. In this review we examine how stem cell–based transplantation therapies compare with these novel and emerging treatments in the management of this common condition. J. Comp. Neurol. 522:2802–2816, 2014.
登录
查看更多内容
影响因子：
4.1
作者：
BACKLUND, EO;GRANBERG, PO;OLSON, L
通讯作者：
OLSON, L
影响因子：
5.2
作者：
Brederlau, Anke;Correia, Ana Sofia;Li, Jia-Yi
通讯作者：
Li, Jia-Yi
影响因子：
4
作者：
Cai, Jingli;Yang, Ming;Iacovitti, Lorraine
通讯作者：
Iacovitti, Lorraine
影响因子：
46.9
作者：
Chambers, Stuart M.;Fasano, Christopher A.;Papapetrou, Eirini P.;Tomishima, Mark;Sadelain, Michel;Studer, Lorenz
通讯作者：
Studer, Lorenz
影响因子：
8.6
作者：
Antonini, Angelo;Isaias, Ioannis U.;Pezzoli, Gianni
通讯作者：
Pezzoli, Gianni